Product NDC: | 65224-545 |
Proprietary Name: | Aldex CT |
Non Proprietary Name: | PHENYLEPHRINE HYDROCHLORIDE and DIPHENHYDRAMINE HYDROCHLORIDE |
Active Ingredient(s): | 12.5; 5 mg/1; mg/1 & nbsp; PHENYLEPHRINE HYDROCHLORIDE and DIPHENHYDRAMINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65224-545 |
Labeler Name: | Pernix Therapeutics, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100120 |
Package NDC: | 65224-545-01 |
Package Description: | 100 TABLET, CHEWABLE in 1 BOTTLE (65224-545-01) |
NDC Code | 65224-545-01 |
Proprietary Name | Aldex CT |
Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE (65224-545-01) |
Product NDC | 65224-545 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | PHENYLEPHRINE HYDROCHLORIDE and DIPHENHYDRAMINE HYDROCHLORIDE |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20100120 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Pernix Therapeutics, LLC |
Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 12.5; 5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |